MXPA04002784A - Sales farmaceuticamente aceptables de 20(s)-camptotecinas. - Google Patents

Sales farmaceuticamente aceptables de 20(s)-camptotecinas.

Info

Publication number
MXPA04002784A
MXPA04002784A MXPA04002784A MXPA04002784A MXPA04002784A MX PA04002784 A MXPA04002784 A MX PA04002784A MX PA04002784 A MXPA04002784 A MX PA04002784A MX PA04002784 A MXPA04002784 A MX PA04002784A MX PA04002784 A MXPA04002784 A MX PA04002784A
Authority
MX
Mexico
Prior art keywords
pharmaceutically acceptable
acceptable salts
camptothecins
polymorphs
stereoisomers
Prior art date
Application number
MXPA04002784A
Other languages
English (en)
Inventor
Rajagopal Sriram
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Publication of MXPA04002784A publication Critical patent/MXPA04002784A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

La presente invencion se refiere a sales aceptables farmaceuticamente formadas por los compuestos de formula general (I), sus derivados, sus analogos, sus formas tautomericas, sus estereoisomeros, sus polimorfos y composiciones aceptables farmaceuticamente que las contienen. La presente invencion tambien se refiere a un proceso para preparar las sales aceptables farmaceuticamente antes mencionadas, sus derivados, sus analogos, sus formas tautomericas, sus estereoisomeros, sus polimorfos y composiciones farmaceuticas que las contienen.
MXPA04002784A 2001-09-25 2002-09-25 Sales farmaceuticamente aceptables de 20(s)-camptotecinas. MXPA04002784A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN798MA2001 2001-09-25
PCT/IB2002/003950 WO2003027118A1 (en) 2001-09-25 2002-09-25 Pharmaceutically acceptable salts of 20(s)-camptothecins

Publications (1)

Publication Number Publication Date
MXPA04002784A true MXPA04002784A (es) 2004-07-29

Family

ID=33042623

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002784A MXPA04002784A (es) 2001-09-25 2002-09-25 Sales farmaceuticamente aceptables de 20(s)-camptotecinas.

Country Status (18)

Country Link
US (1) US7071203B2 (es)
EP (1) EP1430059B1 (es)
JP (1) JP2005507893A (es)
KR (1) KR20040039404A (es)
CN (1) CN1575292A (es)
AT (1) ATE318823T1 (es)
BR (1) BR0212990A (es)
CA (1) CA2461089A1 (es)
DE (1) DE60209517D1 (es)
HU (1) HUP0401912A3 (es)
IL (1) IL160982A0 (es)
MX (1) MXPA04002784A (es)
NO (1) NO20041643L (es)
NZ (1) NZ531878A (es)
PL (1) PL368229A1 (es)
RU (1) RU2004109163A (es)
WO (1) WO2003027118A1 (es)
ZA (1) ZA200402321B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003207369A1 (en) * 2002-02-18 2003-09-04 Dr. Reddy's Laboratories Limited A process for the preparation of 10-hydroxy-9-n,n-dimethylaminomethyl-5-(2'-fluoroethoxy)-20(s)-camptothecin hydrochloride
TWI333492B (en) * 2003-11-12 2010-11-21 Smithkline Beecham Cork Ltd Crystalline topotecan hydrochloride product and preparation thereof
WO2006038526A1 (ja) * 2004-10-01 2006-04-13 Kabushiki Kaisha Yakult Honsha イリノテカン酸付加塩
ITMI20061473A1 (it) * 2006-07-26 2008-01-27 Indena Spa Derivati della camptotecina ad attivita antitumorale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1025029C (zh) * 1988-10-22 1994-06-15 沈阳药学院 喜树硷精氨酸盐制剂的制备方法
US6177439B1 (en) * 1995-06-06 2001-01-23 Reddy's Research Foundation Water soluble analogues of 20(S)-camptothecin
JP4094710B2 (ja) * 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体

Also Published As

Publication number Publication date
ZA200402321B (en) 2005-01-13
US20040198760A1 (en) 2004-10-07
DE60209517D1 (de) 2006-04-27
ATE318823T1 (de) 2006-03-15
EP1430059A1 (en) 2004-06-23
EP1430059B1 (en) 2006-03-01
NO20041643L (no) 2004-04-22
IL160982A0 (en) 2004-08-31
CA2461089A1 (en) 2003-04-03
BR0212990A (pt) 2004-09-21
WO2003027118A1 (en) 2003-04-03
PL368229A1 (en) 2005-03-21
HUP0401912A2 (hu) 2005-01-28
US7071203B2 (en) 2006-07-04
CN1575292A (zh) 2005-02-02
JP2005507893A (ja) 2005-03-24
KR20040039404A (ko) 2004-05-10
HUP0401912A3 (en) 2007-02-28
RU2004109163A (ru) 2005-10-10
NZ531878A (en) 2006-04-28

Similar Documents

Publication Publication Date Title
MY121760A (en) Benzothiazin and benzoxazin derivatives;their preparation and uses
WO1999008501A3 (en) New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
MY140057A (en) Novel heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine
NZ504106A (en) Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them
IL127296A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
WO2001090097A3 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
WO2003084938A3 (en) Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
MXPA03005822A (es) Compuestos heterociclicos que tienen actividad antibacteriana, proceso para su preparacion y composiciones farmaceuticas que los contienen.
AP1522A (en) Compounds having hypolipedemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them.
YU60701A (sh) Nova triciklička jedinjenja i njihova upotreba u medicini; postupak za njihovo pripremanje i farmaceutske kompozicije koje ih sadrže
RS48104A (en) New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing theim
YU75101A (sh) Supstituisani biciklični heterocikli, postupak njihove izrade i njihova upotreba kao antigojaznih i hipoholesterolemijskih agenasa
MXPA02009643A (es) Sintesis acortada de derivados de 3,3-diarilpropilamina.
UA66866C2 (uk) Синтез морфолінових похідних
UA72883C2 (uk) Біциклічна сполука, способи її одержання, фармацевтичні композиції, що її містять,способи лікування та попередження різних захворювань, проміжні сполуки та способи їх одержання
MXPA04002784A (es) Sales farmaceuticamente aceptables de 20(s)-camptotecinas.
EP1390343A4 (en) NOVEL RETINOID DERIVATIVES, METHODS FOR PREPARING THESE COMPOUNDS, AND ANTI-CANCER PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
CA2336380A1 (en) Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
WO2002062798A3 (en) Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
WO2005035528A3 (en) Triazole derivatives as antibacterial agents
HUP0104213A2 (hu) Vankoreszmicin, eljárás előállítására és gyógyszerként történő alkalmazása
RS20050426A (en) Substituted aralkyl derivatives
RS32404A (en) Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them
MY131832A (en) New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
MXPA04004537A (es) Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos.